677: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?
676: Are standard doses of apixaban as effective as warfarin in severe obesity?
675: How to judge whether a journal is reputable?
674: Why 3 days of outpatient remdesivir is probably not going to catch on
673: Is this a better metric for antibiotic stewardship?
672: Is there finally a clinically relevant reason to choose ketamine over etomidate for RSI?
671: What predicts critical care pharmacist intervention – patient acuity or medication regimen complexity?
670: How to answer a question like an experienced pharmacist, even if you’re brand new
669: Is this the most important article on vancomycin ever published?
668: Is oral valganciclovir really as good as IV ganciclovir for the treatment of CMV infection?
667: If Nebulized Formoterol is Compatible with Most Other Nebulized Medications, Why Are They Not Recommended To Be Mixed?
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 93
- Next Page »